Pretreatment thrombocytosis in breast cancer and its prognostic implication: a review

Authors

  • Dr. Deepti Sharma VMMC andSafdarjung Hospital, New Delhi, India

DOI:

https://doi.org/10.21276/apjhs.2016.3.4s.1

Keywords:

Platelets, Thrombocytosis, Interleukin-6. breast cancer

Abstract

Thrombocytosis has been suggested to be a poor prognostic indicator in malignancies. Platelet granules contain a variety of growth factors which are secreted immediately after platelet activation which have been implicated in tumor progression and in the development of metastasis. Studies have shown that thrombocytosis is associated with a poor prognosis in various gyanecological and non gynaecological malignancies. This independent prognostic factor may provide a simple approach to improved risk stratification of patients in future clinical trials.

Downloads

Download data is not yet available.

Author Biography

Dr. Deepti Sharma, VMMC andSafdarjung Hospital, New Delhi, India

Assistant Professor, Radiation Oncology

Downloads

Published

2016-12-30

How to Cite

Dr. Deepti Sharma. (2016). Pretreatment thrombocytosis in breast cancer and its prognostic implication: a review. Asian Pacific Journal of Health Sciences, 3(4(S), 1–4. https://doi.org/10.21276/apjhs.2016.3.4s.1

Issue

Vol. 3 No. 4(S) (2016): Vol 3 | Issue 4(S), October - December 2016

Section

Table of Contents

License

Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.